[Disseminated lymphangioleiomyomatosis].
Klein
M
M
Geburtshilflich-gynäkologische Abteilung, Hanusch-Krankenhaus, Wien.
Krieger
O
O
Ruckser
R
R
Rosen
A
A
Waldner
R
R
Preis
P
P
Beck
A
A
D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007044:Hysterectomy; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008203:Lymphangiomyoma / Q000628:therapy*; D008479:Mediastinal Neoplasms / Q000628:therapy*; D010052:Ovariectomy; D010386:Pelvic Neoplasms / Q000628:therapy*; D010534:Peritoneal Neoplasms / Q000628:therapy*; D016066:Pleural Effusion, Malignant / Q000628:therapy*; D011994:Recombinant Proteins; D013629:Tamoxifen / Q000008:administration & dosage
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D013629:Tamoxifen
Disseminierte Lymphangioleiomyomatose.